Association of two apolipoprotein A-I gene MspI polymorphisms with high density lipoprotein (HDL)-cholesterol levels and indices of obesity in selected healthy Chinese subjects and in patients with early-onset type 2 diabetes

Clinical Endocrinology

Volumn 59, Issue 4, 2003, Pages 442-449

  Ma, Yan Qing ^a   Thomas, G Neil ^a,b   Ng, Maggie C Y ^a   Critchley, Julian A J H ^a   Cockram, Clive S ^a   Chan, Juliana C N ^a   Tomlinson, Brian ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY MASS; CHINESE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ONSET AGE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SEX DIFFERENCE;

ADULT; APOLIPOPROTEIN A-I; BODY CONSTITUTION; BODY MASS INDEX; CHINA; CHOLESTEROL, HDL; DIABETES MELLITUS, TYPE 2; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HOMOZYGOTE; HONG KONG; HUMANS; MALE; OBESITY; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

EID: 0141839694     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2003.01865.x     Document Type: Article

References (43)

1. Anderson, R.A., Benda, T.J., Wallace, R.B., Eliason, S.L., Lee, J. & Burns, T.L. (1986) Prevalence and associations of apolipoprotein A-I linked DNA polymorphisms: results from a population study. Genetic Epidemiology, 3, 385-397.
2. Angotti, E., Mele, E., Costanzo, F. & Avvedimento, E.V. (1994) A polymorphism (G → A transition) in the -78 position of the apolipoprotein A-I promoter increases transcription efficiency. Journal of Biological Chemistry, 269, 17371-17374.
3. Badimon, J.J., Fuster, V. & Badimon, L. (1992) Role of high density lipoproteins in the regression of atherosclerosis. Circulation, 86, III86-94.
4. Breier, C., Muhlberger, V., Drexel, H., Herold, M., Lisch, H.J., Knapp, E. & Braunsteiner, H. (1985) Essential role of post-heparin lipoprotein lipase activity and of plasma testosterone in coronary artery disease. Lancet, 1, 1242-1244.
5. Chan, J.C.N. & Cockram, C.S. (1997) Diabetes in the Chinese population and its implications for health care. Diabetes Care, 20, 1785-1790.
6. Dallinga-Thie, G.M., Bu, X.D., van Linde-Sibenius Trip, M., Rotter, J.I., Lusis, A.J. & de Bruin, T.W. (1996) Apolipoprotein A-I/C-III/A-IV gene cluster in familial combined hyperlipidemia: effects on LDL-cholesterol and apolipoproteins B and C-III. Journal of Lipid Research, 37, 136-147.
7. Durack-Bown, I., Fumeron, F., Betoulle, D., Chevreuil, O. & Apfelbaum, M. (1994) Xmn1 restriction polymorphism of apolipoprotein AI gene and lipoprotein levels in obesity. International Journal of Obesity and Related Metabolic Disorders, 18, 460-464.
8. von Eckardstein, A., Walter, M., Holz, H., Benninghoven, A. & Assmann, G. (1991) Site-specific methionine sulfoxide formation is the structural basis of chromatographic heterogeneity of apolipoproteins A-I, C-II, and C-III. Journal of Lipid Research, 32, 1465-1476.
9. Francone, O.L., Gurakar, A. & Fielding, C. (1989) Distribution and functions of lecithin: cholesterol acyltransferase and cholesteryl ester transfer protein in plasma lipoproteins. Evidence for a functional unit containing these activities together with apolipoproteins A-I and D that catalyzes the esterification and transfer of cell-derived cholesterol. Journal of Biological Chemistry, 264, 7066-7072.
10. Francone, O.L., Royer, L. & Haghpassand, M. (1996) Increased prebeta-HDL levels, cholesterol efflux, and LCAT-mediated esterification in mice expressing the human cholesteryl ester transfer protein (CETP) and human apolipoprotein A-I (apoA-I) transgenes. Journal of Lipid Research, 37, 1268-1277.
11. Goldbourt, U., Yaari, S. & Medalie, J.H. (1997) Isolated low HDL cholesterol as a risk factor for coronary heart disease mortality. A 21-year follow-up of 8000 men. Arteriosclerosis, Thrombosis and Vascular Biology, 17, 107-113.
12. Hansen, B.C. (1999) The metabolic syndrome X. Annals of the New York Academy of Sciences, 892, 1-24.
13. Hausmann, D., Johnson, J.A., Sudhir, K., Mullen, W.L., Friedrich, G., Fitzgerald, P.J., Chou, T.M., Ports, T.A., Kane, J.P., Malloy, M.J. & Yock, P.G. (1996) Angiographically silent atherosclerosis detected by intravascular ultrasound in patients with familial hypercholesterolaemia and familial combined hyperlipidaemia: correlation with high density lipoproteins. Journal of the American College of Cardiology, 27, 1562-1570.
14. Iverius, P.H. & Brunzell, J.D. (1988) Relationship between lipoprotein lipase activity and plasma sex steroid level in obese women. Journal of Clinical Investigation, 82, 1106-1112.
15. Janus, E.D. for the Cardiovascular Risk Factor Prevalence Study Group (1997) Hong Kong Cardiovascular Risk Factor Prevalence Study 1995-1996. Hong Kong.
16. Kamboh, M.I., Aston, C.E., Nestlerode, C.M., McAllister, A.E. & Hamman, R.F. (1996) Haplotype analysis of two apoA-I/MspI polymorphisms in relation to plasma levels of apoA-I and HDL-cholesterol. Atherosclerosis, 127, 255-262.
17. Kessling, A.M., Horsthemke, B. & Humphries, S.E. (1985) A study of DNA polymorphisms around the human apolipoprotein AI gene in hyperlipidaemic and normal individuals. Clinical Genetics, 28, 296-306.
18. Ko, G.TC., Chan, J.C.N. & Cockram, C.S. (1998) The association between dyslipidaemia and obesity in Chinese men after adjustment for insulin resistance. Atherosclerosis, 138, 153-161.
19. Lopez-Miranda, J., Ordovas, J.M., Espino, A., Marin, C., Salas, J., Lopez-Segura, F., Jimenez-Pereperez, J. & Perez-Jimenez, F. (1994) Influence of mutation in human apolipoprotein A-1 gene promoter on plasma LDL cholesterol response to dietary fat. Lancet, 343, 1246-1249.
20. Marasco, O., Melina, F., Mele, E., Quaresima, B., Zingone, A., Focarelli, E., Picciotti, E., Martelli, M.L., Fotino, L., Vigna, M.F., Baudi, F., Dominijanni, A., Angotti, E., Pujia, A., Perrotti, N., Colonna, A., Mattioli, P., Porcellini, A., Costanzo, F. & Avvedimento, V.E. (1993) Linkage disequilibrium of three polymorphic RFLP markers in the apolipoprotein AI-CIII gene cluster on chromosome II. Human Genetics, 91, 169-174.
21. Meng, Q.H., Pajukanta, P., Valsta, L., Aro, A., Pietinen, P. & Tikkanen, M.J. (1997) Influence of apolipoprotein A-1 promoter polymorphism on lipid levels and responses to dietary change in Finnish adults. Journal of Internal Medicine, 241, 373-378.
22. Norum, R.A., Lakier, J.B., Goldstein, S., Angel, A., Goldberg, R.B., Block, W.D., Noffze, D.K., Dolphin, P.J., Edelglass, J., Bogorad, D.D. & Alaupovic, P. (1982) Familial deficiency of apolipoproteins A-I and C-III and precocious coronary-artery disease. New England Journal of Medicine, 306, 1513-1519.
23. Pagani, F., Sidoli, A., Giudici, G.A., Barenghi, L., Vergani, C. & Baralle, F.E. (1990) Human apolipoprotein A-I gene promoter polymorphism: association with hyperalphalipoproteinemia. Journal of Lipid Research, 31, 1371-1377.
24. Paul-Hayase, H., Rosseneu, M., Robinson, D., Van Bervliet, J.P., Deslypere, J.P. & Humphries, S.E. (1992) Polymorphisms in the apolipoprotein (apo) AI-CIII-AIV gene cluster: detection of genetic variation determining plasma apo AI, apo CIII and apo AIV concentrations. Human Genetics, 88, 439-446.
25. Pulkkinen, A., Viitanen, L., Kareinen, A., Lehto, S. & Laakso, M. (2000) MspI polymorphism at +83 bp in intron 1 of the human apolipoprotein A1 gene is associated with elevated levels of HDL cholesterol and apolipoprotein A1 in nondiabetic subjects but not in type 2 diabetic patients with coronary heart disease. Diabetes Care, 23, 791-795.
26. Saha, N., Tay, J.S., Low, P.S. & Humphries, S.E. (1994) Guanidine to adenine (G/A) substitution in the promoter region of the apolipoprotein AI gene is associated with elevated serum apolipoprotein AI levels in Chinese non-smokers. Genetic Epidemiology, 11, 255-264.
27. Saito, K., Sakurabayashi, I. & Manabe, M. (1998) Serum lipoprotein lipase in healthy subjects: effects of gender and age, and relationships to lipid parameters. Annals of Clinical Biochemistry, 35, 733-738.
28. Sigurdsson, G., Jr, Gudnason, V., Sigurdsson, G. & Humphries, S.E. (1992) Interaction between a polymorphism of the apo A-I promoter region and smoking determines plasma levels of HDL and apo A-1. Arteriosclerosis and Thrombosis, 12, 1017-1022.
29. Smith, J.D., Brinton, E.A. & Breslow, J.L. (1992) Polymorphism in the human apolipoprotein A-I gene promoter region. Association of the minor allele with decreased production rate in vivo and promoter activity in vitro. Journal of Clinical Investigation, 89, 1796-1800.
30. Steinmetz, J., Boerwinkle, E., Gueguen, R., Visvikis, S., Henny, J. & Siest, G. (1992) Multivariate genetic analysis of high density lipoprotein particles. Atherosclerosis, 92, 219-227.
31. Talmud, P.J., Ye, S. & Humphries, S.E. (1994) Polymorphism in the promoter region of the apolipoprotein AI gene associated with differences in apolipoprotein AI levels: the European Atherosclerosis Research Study. Genetic Epidemiology, 11, 265-280.
32. Thomas, G.N., Tomlinson, B., Chan, J.C., Young, R.P. & Critchley, J.A. (2000a) The Trp64Arg polymorphism of the beta3-adrenergic receptor gene and obesity in Chinese subjects with components of the metabolic syndrome. International Journal of Obesity and Related Metabolic Disorders, 24, 545-551.
33. Thomas, G.N., Tomlinson, B. & Critchley, J.A.J.H. (2000b) Modulation of blood pressure and obesity by the dopamine D2 receptor gene TaqI polymorphism. Hypertension, 36, 177-182.
34. Thomas, G.N., Critchley, J.A.J.H., Tomlinson, B., Cockram, C.S. & Chan, J.C.N. (2001) Relationships between the TaqI polymorphism of the dopamine D2 receptor and blood pressure in hyperglycaemic and normoglycaemic Chinese subjects. Clinical Endocrinology, 55, 605-612.
35. Tonolo, G., Ciccarese, M., Brizzi, P., Milia, S., Dessole, S., Puddu, L., Secchi, G. & Maioli, M. (1995) Cyclical variation of plasma lipids, apolipoproteins, and lipoprotein (a) during menstrual cycle of normal women. American Journal of Physiology, 269, E1101-E1105.
36. Wang, X.L., Badenhop, R., Humphrey, K.E. & Wilcken, D.E. (1995) C to T and/or G to A transitions are responsible for loss of a MspI restriction site at the 5′-end of the human apolipoprotein AI gene. Human Genetics, 95, 473-474.
37. Wang, X.L., Badenhop, R., Humphrey, K.E. & Wilcken, D.E. (1996a) New MspI polymorphism at +83 bp of the human apolipoprotein AI gene: association with increased circulating high density lipoprotein cholesterol levels. Genetic Epidemiology, 13, 1-10.
38. Wang, X.L., Liu, S.X., McCredie, R.M. & Wilcken, D.E. (1996b) Polymorphisms at the 5′-end of the apolipoprotein AI gene and severity of coronary artery disease. Journal of Clinical Investigation, 98, 372-377.
39. Wile, D.B., Barbir, M., Gallagher, J., Myant, N.B., Ritchie, C.D., Thompson, G.R. & Humphries, S.E. (1989) Apolipoprotein A-I gene polymorphisms: frequency in patients with coronary artery disease and healthy controls and association with serum apoA-I and HDL-cholesterol concentration. Atherosclerosis, 78, 9-18.
40. World Health Organization (1985) Diabetes mellitus: a report of a WHO Study Group. World Health Organization, Geneva.
41. Wu, J.H., Wen, M.S., Lo, S.K. & Wu, D. (1993) DNA polymorphisms of apolipoprotein B in the population of Taiwan. Journal of the Formosan Medical Association, 92, 330-335.
42. Xu, C.F., Angelico, F., Del Ben, M. & Humphries, S. (1993) Role of genetic variation at the apo AI-CIII-AIV gene cluster in determining plasma apo AI levels in boys and girls. Genetic Epidemiology, 10, 113-122.
43. Zhang, Q., Liu, Y., Liu, B.W., Fan, P., Cavanna, J. & Galton, D.J. (1998) Common genetic variants of lipoprotein lipase and apolipoproteins AI-CIII that relate to coronary artery disease: a study in Chinese and European subjects. Molecular Genetics and Metabolism, 64, 177-183.